GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cormedix Inc (STU:19KA) » Definitions » Shiller PE Ratio

Cormedix (STU:19KA) Shiller PE Ratio : (As of Jun. 09, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Cormedix Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cormedix Shiller PE Ratio Historical Data

The historical data trend for Cormedix's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cormedix Shiller PE Ratio Chart

Cormedix Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cormedix Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cormedix's Shiller PE Ratio

For the Biotechnology subindustry, Cormedix's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cormedix's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cormedix's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cormedix's Shiller PE Ratio falls into.



Cormedix Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Cormedix's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Cormedix's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.23/131.7762*131.7762
=-0.230

Current CPI (Mar. 2024) = 131.7762.

Cormedix Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.184 100.560 -0.241
201409 -0.892 100.428 -1.170
201412 -0.365 99.070 -0.485
201503 -1.063 99.621 -1.406
201506 -0.579 100.684 -0.758
201509 -0.624 100.392 -0.819
201512 -0.459 99.792 -0.606
201603 -0.494 100.470 -0.648
201606 -0.579 101.688 -0.750
201609 -1.025 101.861 -1.326
201612 -0.758 101.863 -0.981
201703 -0.888 102.862 -1.138
201706 -0.445 103.349 -0.567
201709 -0.713 104.136 -0.902
201712 -0.634 104.011 -0.803
201803 -0.551 105.290 -0.690
201806 -0.445 106.317 -0.552
201809 -0.463 106.507 -0.573
201812 0.088 105.998 0.109
201903 -0.195 107.251 -0.240
201906 -0.027 108.070 -0.033
201909 -1.226 108.329 -1.491
201912 -0.189 108.420 -0.230
202003 -0.190 108.902 -0.230
202006 -0.124 108.767 -0.150
202009 -0.187 109.815 -0.224
202012 -0.156 109.897 -0.187
202103 -0.168 111.754 -0.198
202106 -0.100 114.631 -0.115
202109 -0.187 115.734 -0.213
202112 -0.177 117.630 -0.198
202203 -0.163 121.301 -0.177
202206 -0.180 125.017 -0.190
202209 -0.172 125.227 -0.181
202212 -0.189 125.222 -0.199
202303 -0.224 127.348 -0.232
202306 -0.231 128.729 -0.236
202309 -0.159 129.860 -0.161
202312 -0.238 129.419 -0.242
202403 -0.230 131.776 -0.230

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cormedix  (STU:19KA) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Cormedix Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Cormedix's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cormedix (STU:19KA) Business Description

Traded in Other Exchanges
Address
300 Connell Drive, Suite 4200, Berkeley Heights, NJ, USA, 07922
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's primary focus is to develop its lead product candidate, DefenCath, for potential commercialization in the United States (U.S.) and other key markets.

Cormedix (STU:19KA) Headlines

No Headlines